Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Portugal Tobacco law amendment tabled in Parliament…
  • Vietnam Tobacco harm prevention and control strategy signed…
  • World WHO holds 76th World Health Assembly…
  • Uzbekistan Bill banning novel products to under-21s is published…
  • Australia Queensland toughens anti-smoking and illicit tobacco law…
  • Switzerland Tobacco advertising ban to be extended by popular request…
  • Czech Republic Ministry plans tax on pouches and increases for heated tobacco…
  • Uzbekistan Sale of novel tobacco products to under-21s is banned…
  • Switzerland Committee calls for report on taxation of new tobacco products…
  • Belgium BAT appeals to top court against nicotine pouch ban…
  • Lithuania Parliament backs 12-year plan to cut tobacco use…
  • United States Health equality expert joins federal tobacco watchdog…
View all
News analysis

PMI is cleared of misleading investors over Japanese prospects for Iqos

Written by || 17th February 2020 || News analysis | Heated tobacco | IQOS | Asia Japan North America United States

Philip Morris International (PMI) did not deliberately mislead investors about clinical trials for its Iqos heated tobacco system or about the product’s prospects in Japan, a US federal court has ruled ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Boom in IQOS figures reveals HnB’s rising share of world tobacco market
Comparative interest in IQOS among closed-system users in US and Canada
FDA gives the green light for IQOS roll-out onto the US market
© 2023
TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence,
does not accept any liability or responsibility for information or views published.